References
- Kariminejad A, Bozorgmehr B, Khatami A, Kariminejad MH, Giunta C, Steinmann B. Ehlers-Danlos Syndrome Type VI in a 17-year-old Iranian boy with severe muscular weakness - a diagnostic challenge? Iran J Pediatr. 2010;20(3):358–62. PMID: 23056730.
- Gharbiya M, Moramarco A, Castori M, Parisi F, Celletti C, Marenco M, Mariani I, Grammatico P, Camerota F, et al. Ocular features in joint hypermobility syndrome/ehlers-danlos syndrome hypermobility type: a clinical and in vivo confocal microscopy study. Am J Ophthalmol. 2012 Sep;154(3):593–600.e1. doi: 10.1016/j.ajo.2012.03.023. Epub 2012 May 24. PMID: 22633352.
- De Paepe A, Malfait F. Bleeding and bruising in patients with Ehlers-Danlos syndrome and other collagen vascular disorders. Br J Haematol. 2004;127(5):491–500. doi:10.1111/j.1365-2141.2004.05220.x.
- Artoni A, Bassotti A, Abbattista M, Marinelli B, Lecchi A, Gianniello F, Clerici M, Bucciarelli P, La Marca S, Peyvandi F, et al. Hemostatic abnormalities in patients with Ehlers-Danlos syndrome. J Thromb Haemost. 2018;16(12):2425–31. doi:10.1111/jth.14310.
- D’-Hondt S, Van Damme T, Malfait F. Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review. Genet Med. 2018;20(6):562–73. doi:10.1038/gim.2017.138.
- Stockschlaeder M, Schneppenheim R, Budde U. Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis. Blood Coagul Fibrinolysis. 2014;25(3):206–16. doi:10.1097/MBC.0000000000000065.
- Berntorp E. Haemate P/Humate-P: a systematic review. Thromb Res. 2009;124:S11–S14. doi:10.1016/S0049-3848(09)70152-5.